In accordance with our original hypothesis (38), we have recently shown that extremely low doses of NGR-TNF (5 ng/Kg) are sufficient to induce the up-regulation of VCAM-1 and ICAM-2 on the endothelial lining of tumor vessels as well as the release, in the tumor microenvironment, of chemokines that favor T-cell trafficking (Figure 2B). This evidence concerns the gene ICAM2 and neoplasm.